Sign in
4

Changes in Ownership

KALA BIO, Inc. Filed Acc 0001415889-23-000636

CHIEF EXECUTIVE OFFICER sold 198 shares at $28.54 ($5,651)

  • CHIEF EXECUTIVE OFFICER acquired 41,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-01-04 Grant or award +41,700 46,164 D
Iwicki Mark T CHIEF EXECUTIVE OFFICER 2023-01-04 Sale −198 $28.54 $5,651 45,966 D
Open-market sales · 198 sh · avg $28.54 · $5,651
Loading xslF345X03/form4-01062023_080102.xml…